Home

Marvin Slosman

CIK 1796908 · CEO and President · last filed 2026-07-07

Marvin Slosman is a CEO and President who has filed 14 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for BCDA, was dated Jul 7, 2026. Across all open-market trades the lifetime net is +$100.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.43M

Companies

4

Total Filings

14

Lifetime Open-Market Net

$100.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCDA Director — $0.78 — $0 2 2026-07-07
NSPR CEO and President 3,556,658 $0.68 $2.43M $50.2K 6 2026-05-13
InspireMD, Inc. (NSPRZ) Delisted CEO and President 243,470 $0.01 $2.2K $0 1 2021-10-14
InspireMD, Inc. (NSPR.WS.B) Delisted CEO and President 1,453,538 $0.03 $43.5K $50.0K 5 2021-04-21

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-07 BCDA Grant (A) — $0 EDGAR
2026-05-13 NSPR Buy (P) +21,000 $25.2K EDGAR
2026-01-16 NSPR Grant (A) +1,114,792 $0 EDGAR
2025-12-10 BCDA Grant (A) — $0 EDGAR
2025-08-01 NSPR Buy (P) +10,330 $25.0K EDGAR
2025-01-10 NSPR Grant (A) +558,417 $0 EDGAR
2024-01-25 NSPR Grant (A) +563,499 $0 EDGAR
2023-05-19 NSPR Grant (A) +1,045,150 $0 EDGAR
2021-10-14 InspireMD, Inc. (NSPRZ) Delisted Grant (A) +146,567 $0 EDGAR
2021-04-21 InspireMD, Inc. (NSPR.WS.B) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.